In March, laboratory-based research at Harvard was put on hold, maintaining only the most critical functions to safeguard materials that are essential to our mission of finding cures and better treatments for human disease. In May, the university announced its research laboratory re-entry plan, and has been preparing for re-entry in fidelity with federal, state, local and university policy and requirements. Visit the Harvard University coronavirus website for university-wide information, and the ISSCR coronavirus page for stem-cell community resources.
Read more about HSCI
- Blood Diseases
- Cardiovascular Diseases
- Musculoskeletal Disease
- Nervous System Diseases
- Skin Diseases
- Fibrosis & Aging
- Stem Cells as Tools
All Research Areas
Protecting beta cells against type 1 diabetes
Gut microbiome influences ALS outcomes
HSCI scientists identify gut-brain connection in ALS
HSCI has been breaking down barriers to collaboration in stem cell science since 2004. We provide fertile ground for more than 350 research faculty and their labs, across the university’s schools, centers, teaching hospitals, and partner companies, to share knowledge and pursue bold new ideas.
With Harvard as a wellspring of discovery and a strong network that embraces new ways of working, we are better equipped than ever to change human health in ways that will benefit all of society.